Loading
CRISPR and Genetic Engineering · Journal article
Journal of Pharmacognosy and Phytochemistry · September 1, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review of CRISPR-Cas9 technology and its proposed applications across multiple disease domains (cancer, cardiovascular, renal, neurological, lung, and neurodegenerative disease). The article summarizes the mechanism of action and conceptual therapeutic potential but reports no original empirical data, clinical trial results, or quantified efficacy outcomes.
Journal article.
CRISPR-Cas9 is described as accurate, efficient, and compatible for targeted genetic modifications across cell types and organisms Technology is proposed as useful in cancer research through functional screening, targeting oncogenes, and enhancing CAR-T immunotherapy Multiple disease categories are listed as potentially treatable: cardiovascular diseases, renal diseases, neurological disorders, lung diseases, osteoarthritis, and neurodegenerative diseases
No clinical trial data, efficacy measures, or safety outcomes reported
The source did not state who this applies to in practice.
This is a narrative review summarizing CRISPR-Cas9 mechanisms and potential applications across disease areas without reporting original empirical data, clinical outcomes, or comparative evidence.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein that is Cas9 (CRISPR-Cas9) has become a next-level and highly useful gene-editing technology due to its accuracy, efficiency, and compatibility. This is a more powerful tool for targeted genetic modifications in any cell types and organisms. Cas9 nuclease, directed toward a specific DNA sequence with the help of single-guided RNA (sgRNA), generates double-strand breaks by itself, and these are repaired by non-homologous end joining. This review article gives you a view of the CRISPR-Cas9 mechanism and highlights its vast role in the treatment of human disease. Several diseases have more complicated treatments, but by using this genome editing technology (CRISPR-Cas9), those treatments become much easier. This technology is highly useful in cancer research and treatment due to functional screening, targeting oncogenes, and enhancing immunotherapeutic strategies, including CAR-T therapy. Many more diseases are cured by using CRISPR-Cas9 technology, such as cardiovascular diseases, renal diseases, neurological disorders, lung diseases, osteoarthritis, and neurodegenerative diseases. By continuing research and development on this tool, more advanced technology can be created.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.